Allergan, Inamed Smooth Out Concerns Over Reloxin
Botox marketer Allergan Inc. and Inamed Corp. have agreed to divest the rights to rival wrinkle buster Reloxin to alleviate concerns over the potential anti-competitive effects of their billion-dollar merger....To view the full article, register now.
Already a subscriber? Click here to view full article